1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Perez, J.M.J.
Siegal, G.
Kriek, J.
Hard, K.
Dijk, J.
Canters, G.W.
Moller, W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure Fold.Des.
FODEFH
1263
0969-2126
7
217
226
10.1016/S0969-2126(99)80027-6
10368288
The solution structure of the guanine nucleotide exchange domain of human elongation factor 1beta reveals a striking resemblance to that of EF-Ts from Escherichia coli.
1999
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
12
467
1H, 15N and 13C Chemical Shift Assignment of the Guanine Nucleotide Exchange Domain of Human Elongation Factor-One Beta
1998
10.2210/pdb1b64/pdb
pdb_00001b64
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
10148.631
ELONGATION FACTOR 1-BETA
GUANINE EXCHANGE FACTOR DOMAIN
1
man
polymer
no
no
MLVAKSSILLDVKPWDDETDMAKLEECVRSIQADGLVWGSSKLVPVGYGIKKLQIQCVVEDDKVGTDMLEEQITAFEDYV
QSMDVAAFNKI
MLVAKSSILLDVKPWDDETDMAKLEECVRSIQADGLVWGSSKLVPVGYGIKKLQIQCVVEDDKVGTDMLEEQITAFEDYV
QSMDVAAFNKI
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
BL21
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PLASMID
PET11A
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1999-05-18
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1999-01-20
REL
REL
THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY OF 13C, 15N-LABELED EF-1BETA.
LEAST RESTRAINT VIOLATION
50
20
VARIOUS
100 mM
6.9
1
atm
303
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
simulated annealing
95% H2O AND 5% D2O
GUNTERT,WUTHRICH
refinement
DYANA
1.4
structure solution
DYANA V.1.4
V.1.4
600
Bruker
DMX600
MET
1
n
1
MET
1
A
LEU
2
n
2
LEU
2
A
VAL
3
n
3
VAL
3
A
ALA
4
n
4
ALA
4
A
LYS
5
n
5
LYS
5
A
SER
6
n
6
SER
6
A
SER
7
n
7
SER
7
A
ILE
8
n
8
ILE
8
A
LEU
9
n
9
LEU
9
A
LEU
10
n
10
LEU
10
A
ASP
11
n
11
ASP
11
A
VAL
12
n
12
VAL
12
A
LYS
13
n
13
LYS
13
A
PRO
14
n
14
PRO
14
A
TRP
15
n
15
TRP
15
A
ASP
16
n
16
ASP
16
A
ASP
17
n
17
ASP
17
A
GLU
18
n
18
GLU
18
A
THR
19
n
19
THR
19
A
ASP
20
n
20
ASP
20
A
MET
21
n
21
MET
21
A
ALA
22
n
22
ALA
22
A
LYS
23
n
23
LYS
23
A
LEU
24
n
24
LEU
24
A
GLU
25
n
25
GLU
25
A
GLU
26
n
26
GLU
26
A
CYS
27
n
27
CYS
27
A
VAL
28
n
28
VAL
28
A
ARG
29
n
29
ARG
29
A
SER
30
n
30
SER
30
A
ILE
31
n
31
ILE
31
A
GLN
32
n
32
GLN
32
A
ALA
33
n
33
ALA
33
A
ASP
34
n
34
ASP
34
A
GLY
35
n
35
GLY
35
A
LEU
36
n
36
LEU
36
A
VAL
37
n
37
VAL
37
A
TRP
38
n
38
TRP
38
A
GLY
39
n
39
GLY
39
A
SER
40
n
40
SER
40
A
SER
41
n
41
SER
41
A
LYS
42
n
42
LYS
42
A
LEU
43
n
43
LEU
43
A
VAL
44
n
44
VAL
44
A
PRO
45
n
45
PRO
45
A
VAL
46
n
46
VAL
46
A
GLY
47
n
47
GLY
47
A
TYR
48
n
48
TYR
48
A
GLY
49
n
49
GLY
49
A
ILE
50
n
50
ILE
50
A
LYS
51
n
51
LYS
51
A
LYS
52
n
52
LYS
52
A
LEU
53
n
53
LEU
53
A
GLN
54
n
54
GLN
54
A
ILE
55
n
55
ILE
55
A
GLN
56
n
56
GLN
56
A
CYS
57
n
57
CYS
57
A
VAL
58
n
58
VAL
58
A
VAL
59
n
59
VAL
59
A
GLU
60
n
60
GLU
60
A
ASP
61
n
61
ASP
61
A
ASP
62
n
62
ASP
62
A
LYS
63
n
63
LYS
63
A
VAL
64
n
64
VAL
64
A
GLY
65
n
65
GLY
65
A
THR
66
n
66
THR
66
A
ASP
67
n
67
ASP
67
A
MET
68
n
68
MET
68
A
LEU
69
n
69
LEU
69
A
GLU
70
n
70
GLU
70
A
GLU
71
n
71
GLU
71
A
GLN
72
n
72
GLN
72
A
ILE
73
n
73
ILE
73
A
THR
74
n
74
THR
74
A
ALA
75
n
75
ALA
75
A
PHE
76
n
76
PHE
76
A
GLU
77
n
77
GLU
77
A
ASP
78
n
78
ASP
78
A
TYR
79
n
79
TYR
79
A
VAL
80
n
80
VAL
80
A
GLN
81
n
81
GLN
81
A
SER
82
n
82
SER
82
A
MET
83
n
83
MET
83
A
ASP
84
n
84
ASP
84
A
VAL
85
n
85
VAL
85
A
ALA
86
n
86
ALA
86
A
ALA
87
n
87
ALA
87
A
PHE
88
n
88
PHE
88
A
ASN
89
n
89
ASN
89
A
LYS
90
n
90
LYS
90
A
ILE
91
n
91
ILE
91
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
O
HG1
GLU
THR
70
74
1.49
1
A
A
O
H
THR
GLU
66
70
1.49
1
A
A
O
H
LEU
ILE
69
73
1.50
1
A
A
O
H
MET
GLU
21
25
1.53
1
A
A
O
H
LYS
CYS
23
27
1.53
1
A
A
O
H
LYS
GLN
13
81
1.54
2
A
A
O
HE1
ILE
TRP
31
38
1.49
2
A
A
HE1
O
TRP
GLU
15
77
1.54
2
A
A
O
H
LYS
CYS
23
27
1.56
2
A
A
H
O
SER
VAL
6
59
1.56
3
A
A
HE1
O
TRP
GLU
15
77
1.49
3
A
A
O
H
LEU
ILE
69
73
1.51
3
A
A
H
O
SER
VAL
6
59
1.52
3
A
A
OE1
H
GLU
ASP
60
61
1.53
3
A
A
O
H
VAL
VAL
37
58
1.53
3
A
A
O
H
GLU
SER
26
30
1.58
4
A
A
O
H
MET
GLU
21
25
1.50
4
A
A
O
H
LEU
ILE
69
73
1.50
4
A
A
O
H
LYS
GLN
13
81
1.54
4
A
A
O
H
ASP
GLU
67
71
1.56
5
A
A
O
HG1
GLU
THR
70
74
1.47
5
A
A
O
H
LEU
ILE
69
73
1.51
5
A
A
O
H
ALA
GLU
22
26
1.53
5
A
A
O
H
LYS
CYS
23
27
1.53
5
A
A
O
H
LYS
GLN
13
81
1.55
5
A
A
HE1
O
TRP
GLU
15
77
1.58
6
A
A
O
H
LYS
GLN
13
81
1.52
6
A
A
O
H
LEU
ILE
69
73
1.52
6
A
A
O
H
VAL
ILE
28
31
1.54
6
A
A
H
O
SER
VAL
6
59
1.55
7
A
A
O
H
LYS
GLN
13
81
1.53
7
A
A
O
H
LEU
ILE
69
73
1.56
7
A
A
O
H
LYS
CYS
23
27
1.56
7
A
A
O
H
GLU
SER
26
30
1.57
7
A
A
H
O
SER
VAL
6
59
1.58
8
A
A
O
H
LEU
ILE
69
73
1.51
8
A
A
O
H
LYS
GLN
13
81
1.56
8
A
A
O
H
GLU
LYS
60
63
1.57
8
A
A
O
H
VAL
VAL
37
58
1.59
9
A
A
O
H
LEU
ILE
69
73
1.49
9
A
A
O
H
LYS
CYS
23
27
1.53
9
A
A
O
H
LYS
GLN
13
81
1.54
10
A
A
O
H
THR
GLU
66
70
1.48
10
A
A
O
H
LEU
ILE
69
73
1.51
10
A
A
O
H
MET
GLU
21
25
1.55
11
A
A
H
O
SER
VAL
6
59
1.49
11
A
A
O
H
LYS
GLN
13
81
1.49
11
A
A
O
H
ALA
GLU
22
26
1.50
11
A
A
O
H
LYS
CYS
23
27
1.56
11
A
A
O
H
LEU
ILE
69
73
1.57
11
A
A
O
HE1
ILE
TRP
31
38
1.57
12
A
A
O
HG1
GLU
THR
70
74
1.41
12
A
A
O
H
LYS
GLN
13
81
1.51
12
A
A
O
H
LEU
ILE
69
73
1.52
12
A
A
O
H
LYS
CYS
23
27
1.52
12
A
A
O
H
GLU
SER
26
30
1.59
13
A
A
O
H
ALA
GLU
22
26
1.48
13
A
A
O
H
LEU
ILE
69
73
1.49
13
A
A
O
H
LYS
CYS
23
27
1.50
13
A
A
HE1
O
TRP
GLU
15
77
1.51
13
A
A
O
H
LYS
GLN
13
81
1.51
13
A
A
H
O
SER
VAL
6
59
1.52
13
A
A
O
H
GLU
SER
26
30
1.55
14
A
A
O
H
LEU
ILE
69
73
1.51
14
A
A
O
H
LYS
CYS
23
27
1.52
14
A
A
O
H
THR
GLU
66
70
1.53
14
A
A
O
H
GLU
SER
26
30
1.55
14
A
A
O
H
LYS
GLN
13
81
1.59
14
A
A
O
H
ASP
THR
16
19
1.59
14
A
A
O
H
VAL
LYS
44
52
1.59
15
A
A
HA
H
SER
ILE
6
91
1.34
15
A
A
O
H
LYS
GLN
13
81
1.57
15
A
A
O
H
LEU
ILE
69
73
1.58
16
A
A
O
HG1
GLU
THR
70
74
1.46
16
A
A
O
H
LYS
GLN
13
81
1.50
16
A
A
HG
O
SER
ASN
6
89
1.54
16
A
A
O
H
LYS
CYS
23
27
1.59
16
A
A
O
H
LEU
ILE
69
73
1.60
17
A
A
O
HG1
GLU
THR
70
74
1.44
17
A
A
O
H
LEU
ILE
69
73
1.51
17
A
A
O
H
LYS
GLN
13
81
1.51
17
A
A
O
H
LYS
CYS
23
27
1.54
17
A
A
O
H
GLU
SER
26
30
1.56
18
A
A
O
H
THR
GLU
66
70
1.48
18
A
A
O
H
LYS
GLN
13
81
1.53
18
A
A
O
H
LEU
ILE
69
73
1.54
18
A
A
O
H
VAL
LYS
44
52
1.56
19
A
A
O
HG1
GLU
THR
70
74
1.41
19
A
A
O
H
LEU
ILE
69
73
1.50
19
A
A
O
H
THR
GLU
66
70
1.51
19
A
A
OD1
H
ASP
GLU
16
18
1.52
19
A
A
O
H
LEU
ALA
9
86
1.56
19
A
A
O
H
ASP
GLU
67
71
1.56
20
A
A
O
HG1
GLU
THR
70
74
1.43
20
A
A
O
H
LYS
CYS
23
27
1.49
20
A
A
O
H
GLU
SER
26
30
1.49
20
A
A
O
H
LEU
ILE
69
73
1.51
20
A
A
O
H
THR
GLU
66
70
1.53
20
A
A
O
H
LYS
GLN
13
81
1.56
1
A
LEU
2
-48.96
-83.18
1
A
ALA
4
38.99
61.71
1
A
THR
19
-52.74
102.54
1
A
ASP
20
-53.17
102.24
1
A
TYR
48
57.49
164.84
1
A
LEU
53
-102.45
66.91
1
A
ASP
61
62.77
-79.61
1
A
ASP
62
-142.07
26.67
1
A
TYR
79
-151.19
-45.48
1
A
SER
82
-178.69
112.97
1
A
ALA
87
171.86
173.62
2
A
LEU
2
-107.61
75.64
2
A
ALA
4
70.10
83.37
2
A
ASP
11
-150.12
89.32
2
A
ASP
16
168.09
-174.28
2
A
THR
19
-67.23
88.22
2
A
VAL
46
-111.62
-74.28
2
A
TYR
48
53.50
-161.55
2
A
THR
66
-162.90
27.54
2
A
TYR
79
-151.80
-44.03
2
A
SER
82
-179.93
115.65
2
A
ALA
87
176.01
167.78
3
A
ALA
4
84.50
123.24
3
A
ASP
16
-175.16
-171.85
3
A
THR
19
-50.56
101.21
3
A
ASP
20
-52.74
96.94
3
A
LEU
53
-103.28
71.44
3
A
TYR
79
-147.71
-44.91
3
A
SER
82
173.43
114.46
3
A
ALA
87
177.51
171.69
4
A
ALA
4
76.06
111.12
4
A
ASP
16
-174.88
-170.61
4
A
THR
19
-60.75
98.27
4
A
ASP
20
-40.70
104.32
4
A
SER
40
-170.80
141.96
4
A
VAL
46
-91.18
-62.17
4
A
TYR
48
171.10
-38.22
4
A
ASP
62
-146.51
26.08
4
A
LYS
63
-96.05
-70.04
4
A
ALA
75
-39.53
-31.99
4
A
TYR
79
-145.84
-44.10
4
A
SER
82
170.09
115.27
4
A
ALA
87
179.84
170.41
5
A
ALA
4
80.80
84.24
5
A
ASP
16
178.64
-174.39
5
A
ASP
20
-44.90
154.82
5
A
ALA
22
-60.35
-70.64
5
A
VAL
46
-90.41
-155.89
5
A
TYR
48
175.94
-33.84
5
A
LEU
53
-115.69
68.45
5
A
ASP
61
53.75
-89.76
5
A
ASP
62
-151.91
24.44
5
A
THR
66
-76.41
47.57
5
A
ASP
67
-96.28
-64.36
5
A
TYR
79
-153.73
-44.06
5
A
SER
82
179.98
118.65
5
A
ALA
87
171.57
176.79
6
A
ALA
4
77.49
78.14
6
A
ASP
16
179.71
176.72
6
A
THR
19
-47.68
106.65
6
A
ASP
20
-51.41
95.27
6
A
VAL
28
-44.75
-73.50
6
A
SER
40
170.00
133.33
6
A
VAL
46
-96.41
-71.35
6
A
TYR
48
-171.60
82.26
6
A
VAL
58
-150.03
68.77
6
A
ASP
62
-155.96
25.42
6
A
LYS
63
-125.05
-77.38
6
A
TYR
79
-148.69
-44.55
6
A
SER
82
179.35
106.59
6
A
ALA
87
175.58
162.93
7
A
LEU
2
-163.30
111.67
7
A
ALA
4
56.13
82.74
7
A
THR
19
-42.81
98.92
7
A
ASP
20
-47.83
95.01
7
A
TYR
48
49.79
-90.21
7
A
ASP
61
58.96
-83.48
7
A
ASP
62
-142.75
25.82
7
A
TYR
79
-149.09
-43.75
7
A
SER
82
-179.49
112.62
7
A
ALA
87
167.60
169.93
8
A
ALA
4
79.90
90.90
8
A
ASP
16
177.51
-178.40
8
A
VAL
46
-148.48
44.08
8
A
TYR
48
-38.29
96.60
8
A
LEU
53
-101.40
64.58
8
A
ASP
61
47.44
-92.08
8
A
ASP
62
-146.47
24.44
8
A
TYR
79
-150.31
-44.72
8
A
SER
82
177.74
107.00
8
A
ALA
87
167.08
175.95
9
A
LEU
2
-99.27
-154.70
9
A
ALA
4
39.06
41.09
9
A
THR
19
-38.40
114.23
9
A
ASP
20
-59.02
100.54
9
A
ALA
33
-169.51
62.34
9
A
ASP
34
40.87
-90.24
9
A
TRP
38
-106.73
79.66
9
A
SER
40
161.88
129.27
9
A
LEU
53
-100.46
72.68
9
A
ASP
62
-155.06
24.59
9
A
LYS
63
-126.38
-78.60
9
A
THR
66
-164.63
-40.79
9
A
TYR
79
-154.68
-43.13
9
A
SER
82
163.45
117.53
9
A
ALA
87
173.64
145.27
10
A
ALA
4
64.76
98.88
10
A
ASP
16
174.41
-172.98
10
A
THR
19
-46.60
108.46
10
A
ASP
20
-55.27
92.29
10
A
LEU
53
-109.45
74.88
10
A
ASP
61
59.31
-85.62
10
A
TYR
79
-142.05
-42.85
10
A
SER
82
171.16
103.52
10
A
ALA
87
173.95
176.27
11
A
LEU
2
63.33
99.20
11
A
ALA
4
72.58
80.13
11
A
THR
19
-59.97
104.10
11
A
ILE
31
-39.97
123.62
11
A
TYR
48
37.98
86.71
11
A
VAL
58
-119.92
76.12
11
A
ASP
62
-141.62
24.78
11
A
LYS
63
-131.88
-77.23
11
A
TYR
79
-144.19
-44.50
11
A
SER
82
173.68
118.81
11
A
ALA
87
168.24
161.34
12
A
LEU
2
70.06
44.90
12
A
ALA
4
63.64
96.30
12
A
ASP
16
174.30
175.80
12
A
THR
19
-56.38
96.43
12
A
TYR
48
-155.77
87.66
12
A
LEU
53
-116.05
61.74
12
A
TYR
79
-154.68
-43.85
12
A
SER
82
174.56
111.78
13
A
LEU
2
-163.30
50.66
13
A
ALA
4
89.20
78.30
13
A
ASP
16
166.49
-171.11
13
A
THR
19
-62.44
97.83
13
A
ASP
20
-41.75
154.82
13
A
ILE
31
-39.49
122.11
13
A
SER
40
-176.67
131.07
13
A
VAL
46
-135.80
-47.43
13
A
LEU
53
-105.37
60.56
13
A
ASP
67
-112.82
-71.06
13
A
TYR
79
-154.99
-44.14
13
A
SER
82
172.18
112.78
13
A
ALA
87
-175.71
149.51
14
A
ALA
4
38.54
53.02
14
A
ASP
16
177.30
166.81
14
A
THR
19
-57.58
102.80
14
A
ASP
20
-48.33
102.93
14
A
VAL
46
-148.61
58.66
14
A
TYR
48
-37.22
106.28
14
A
LEU
53
-114.08
75.36
14
A
ASP
61
57.70
-86.91
14
A
ILE
73
-56.72
-83.25
14
A
TYR
79
-155.44
-42.03
14
A
SER
82
167.30
119.89
15
A
ALA
4
83.52
90.68
15
A
ASP
16
167.34
170.94
15
A
THR
19
-43.92
102.59
15
A
ASP
20
-49.69
105.24
15
A
SER
40
160.98
135.53
15
A
ASP
62
-155.88
25.20
15
A
LYS
63
-125.73
-76.51
15
A
ASP
67
-44.12
-72.72
15
A
ALA
75
-39.44
-30.33
15
A
TYR
79
-151.77
-41.56
15
A
SER
82
169.61
112.91
15
A
ALA
87
-178.25
-177.57
16
A
ALA
4
72.90
86.77
16
A
ASP
16
173.63
-176.49
16
A
ALA
33
-171.95
147.67
16
A
SER
40
174.72
148.32
16
A
VAL
46
-84.48
-85.58
16
A
TYR
48
-77.19
-157.35
16
A
LEU
53
-100.63
75.46
16
A
VAL
58
-153.50
73.43
16
A
ASP
62
-151.69
25.83
16
A
LYS
63
-113.15
-89.67
16
A
THR
66
-170.86
-40.15
16
A
TYR
79
-145.31
-44.02
16
A
SER
82
-179.85
128.46
16
A
ALA
87
164.90
161.10
17
A
THR
19
-56.63
99.45
17
A
ILE
31
-39.96
127.08
17
A
TYR
48
175.25
-34.03
17
A
LEU
53
-112.95
73.74
17
A
VAL
58
-151.23
78.80
17
A
ASP
62
-160.42
26.30
17
A
LYS
63
-132.33
-64.42
17
A
THR
66
35.09
42.06
17
A
ASP
67
-101.03
-60.01
17
A
PHE
76
-111.51
79.18
17
A
TYR
79
-155.03
-43.80
17
A
SER
82
172.89
112.42
17
A
PHE
88
-153.89
88.26
18
A
ALA
4
88.65
77.43
18
A
ASP
16
-178.47
-176.50
18
A
ASP
20
-52.88
95.02
18
A
LEU
53
-102.74
68.63
18
A
CYS
57
-116.63
-166.97
18
A
VAL
58
-151.39
59.82
18
A
ASP
62
-144.55
25.55
18
A
LYS
63
-131.58
-92.46
18
A
ASP
67
-39.18
-77.32
18
A
TYR
79
-147.62
-41.50
18
A
SER
82
168.57
113.41
18
A
ALA
87
-176.29
145.54
18
A
PHE
88
-155.46
85.73
19
A
LEU
2
-44.93
109.05
19
A
ALA
4
84.12
83.32
19
A
ASP
16
163.09
166.81
19
A
THR
19
-39.98
101.68
19
A
ASP
20
-51.24
99.35
19
A
VAL
46
-106.35
-70.14
19
A
TYR
48
68.61
-63.24
19
A
VAL
58
-108.83
77.01
19
A
ASP
62
-91.02
-67.62
19
A
ASP
67
-44.16
-72.86
19
A
TYR
79
-149.34
-43.87
19
A
SER
82
-176.97
131.69
19
A
PHE
88
-152.68
89.47
20
A
LEU
2
58.07
98.89
20
A
ALA
4
75.64
80.66
20
A
THR
19
-49.93
95.50
20
A
TYR
48
68.73
-64.71
20
A
LEU
53
-108.63
69.61
20
A
ASP
61
68.28
-68.12
20
A
ASP
62
-155.13
27.64
20
A
TYR
79
-153.20
-44.63
20
A
SER
82
174.46
115.49
20
A
ALA
87
170.77
173.37
model building
DYANA
refinement
DYANA
SOLUTION STRUCTURE OF THE GUANINE NUCLEOTIDE EXCHANGE FACTOR DOMAIN FROM HUMAN ELONGATION FACTOR-ONE BETA, NMR, 20 STRUCTURES
1
Y
N
A
ALA
22
A
ALA
22
HELX_P
A
SER
30
A
SER
30
1
H1
9
A
THR
66
A
THR
66
HELX_P
A
THR
74
A
THR
74
1
H2
9
GUANINE NUCLEOTIDE EXCHANGE FACTOR
GUANINE NUCLEOTIDE EXCHANGE FACTOR, G-PROTEIN, TRANSLATION ELONGATION
EF1B_HUMAN
UNP
1
1
P24534
GFGDLKSPAGLQVLNDYLADKSYIEGYVPSQADVAVFEAVSSPPPADLCHALRWYNHIKSYEKEKASLPGVKKALGKYGP
ADVEDTTGSGATDSKDDDDIDLFGSDDEEESEEAKRLREERLAQYESKKAKKPALVAKSSILLDVKPWDDETDMAKLEEC
VRSIQADGLVWGSSKLVPVGYGIKKLQIQCVVEDDKVGTDMLEEQITAFEDYVQSMDVAAFNKI
135
224
1B64
2
91
P24534
A
1
2
91
4
anti-parallel
anti-parallel
anti-parallel
A
VAL
37
A
VAL
37
A
PRO
45
A
PRO
45
A
ILE
50
A
ILE
50
A
GLN
56
A
GLN
56
A
LYS
5
A
LYS
5
A
PRO
14
A
PRO
14
A
VAL
80
A
VAL
80
A
LYS
90
A
LYS
90
INVOLVED WITH GEF REACTION ON EF-1APHA.
Unknown
1
A
TYR
48
A
TYR
48
1
1_555
1
P 1